TPO and kidney disorder: Because TPO neutralization in experimental anti-GBM disease normalized platelet production, significantly reduced chronic thrombo-inflammation, and improved kidney disease outcome, this new set of data strongly support the idea that TPO neutralization could also improve disease outcome in patients with anti-GBM disease and elevated platelet count, on top of standard care treatment.